Literature DB >> 8558635

Value of deoxyribonucleic acid ploidy and nuclear morphometry for prediction of disease progression in renal cell carcinoma.

J L Ruiz-Cerdá1, M Hernández, F Gomis, C D Vera, B F Kimler, J E O'Connor, F Jiménez-Cruz.   

Abstract

PURPOSE: A retrospective study was performed on 108 patients with localized renal cell carcinoma (pT1 to 3a N0M0) to determine whether ploidy and nuclear morphometry are independent predictive factors in addition to stage and grade.
MATERIALS AND METHODS: Deoxyribonucleic acid (DNA) content was analyzed by flow cytometry and nuclear morphometry characterized by 5 nuclear descriptors. A Cox proportional hazards regression model was used to identify significant prognostic factors for disease progression.
RESULTS: A model combining tumor stage and grade, DNA ploidy and nuclear minor axis was chosen as optimal with risk of disease progression increased with increasing tumor stage and grade, DNA aneuploidy and increasing nuclear minor axis.
CONCLUSIONS: This improved ability to predict disease progression in localized renal cell carcinoma may have important clinical use.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8558635

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  2 in total

1.  A non-diploid DNA status is linked to poor prognosis in renal cell cancer.

Authors:  Franziska Büscheck; Christoph Fraune; Martina Kluth; Maximilian Lennartz; Ronald Simon; Claudia Hube-Magg; Christian Morlock; Silvano Barbieri; Carolin Wahl; Christian Eichelberg; Christina Möller-Koop; Doris Höflmayer; Corinna Wittmer; Waldemar Wilczak; Guido Sauter; Margit Fisch; Till Eichenauer; Michael Rink
Journal:  World J Urol       Date:  2020-05-02       Impact factor: 4.226

2.  Evaluation of Nuclear Morphometry and Ki-67 Index in Clear Cell Renal Cell Carcinomas: a Five-Year Study.

Authors:  C S Sheela Devi; S Suchitha; R S Veerendrasagar
Journal:  Iran J Pathol       Date:  2017-04-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.